According to a report by Winter Green Research, the surgical robot market size was $3.2 billion in 2014, and the report said that the North American market is currently the largest market, and due to the government's increased investment in healthcare, the reorganization of the healthcare system and the strengthening of people's awareness of minimally invasive surgeries, the market center of gravity in the future will gradually shift to the Asian market.
And, along with the release of next-generation devices, systems and instruments, surgical robots will move from the current large open surgeries to cover tiny parts of the body. It is expected to reach $20 billion by 2021.
With the continuous development of the robotics industry, the development of medical robots has gradually received more heightened attention worldwide, and the United States has designated surgical treatment machines, prosthetic robots, rehabilitation robots, psychological rehabilitation assistance robots, personal care robots, and intelligent health monitoring systems as the six major research directions for future development.
The European program will establish a "Robotics for Health-care" network to promote the development and application of medical robots in Europe.
Surgical robots, as a branch of medical robots, have also made significant progress, although they have been introduced only 10 years ago.
Currently, research on the use of robots in the medical community has focused on surgical robots, rehabilitation robots, nursing robots and service robots.
Esso, which appeared in 1994, was designed to take instructions from surgeons and control a laparoscopic camera.
Its three phases, Iso-1000, Iso-2000 and Iso-3000, fully characterize interventional procedures.
The machine mimics the function of a human arm, realizing voice-activated setups, eliminating the need for auxiliary personnel to manually control the endoscope, and providing more precise and consistent lens movements than human control, providing the surgeon with a direct, stable view.
By 2014, surgeons had performed more than 75,000 minimally invasive surgeries with Aesop worldwide.
In early 1996, a powerful vision system was developed based on the Aesop robot, and the master-slave remotely operated Zeus robot was introduced.
The Zeus robot is divided into a Surgeon-side system and a Patient-side system. The Surgeon-side system consists of a pair of master hands and a monitor, which allows the surgeon to sit and manipulate the master hand grips and watch the patient's internal condition captured by an endoscope through a monitor on the console.
The da Vinci surgical robot is the most successful and widely used surgical robot in the world, and represents the highest level of surgical robotics available today.
The surgeon does not have direct contact with the patient during surgery, but operates and controls the robot through a three-dimensional vision system and a movement calibration system, and the robotic arm and surgical instruments simulate the completion of the surgeon's technical movements and surgical operations.
Da Vinci Surgical Robotics
Da Vinci Surgical Robotics, also known as the "Endoscopic Surgical Instrumentation Control System", is headquartered in Sunnyvale, California, United States, was founded in 1995 by Intuitive Surgical Robotics (IntuitiveSurgical) own design, Intuitive Surgical, based in Sunnyvale, California, was founded in 1995.
The da Vinci robot was introduced in 1996 with the first generation, and in 2006 with the second generation, the robot's robotic arm had a greater range of motion, allowing doctors to make multiple views without leaving the console.
In 2009, dual consoles, analog controllers, and intraoperative fluorescence visualization technology were added to the second-generation robot, which in turn led to the introduction of the third-generation da Vinci Si system.
The fourth-generation da Vinci Xi system was introduced in 2014, with qualitative improvements in flexibility, precision, and imaging clarity, and the company developed a remote viewing and guidance system in late 2014.
The da Vinci Surgical Robot is currently the world's most successful and widely used surgical robot for general surgery, urology, cardiovascular surgery, thoracic surgery, gynecology, ophthalmology, and pediatric surgery.
The da Vinci Surgical Robot is most commonly used in prostatectomy, and has been increasingly used in heart valve repair and gynecologic surgery.